AUPH (STOCKS)
Aurinia Pharmaceuticals Inc
$15.994100
+0.174100 (+1.10%)
Prev close: $15.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Kevin C. Tang
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $2,057.63M
- Employees
- 300
- P/E (TTM)
- 7.31
- P/B (TTM)
- 3.64
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
6
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$0.25 | $0.20 | +0.0480 | +23.76% |
|
Dec 2025 (Q4)
|
$0.26 | $0.22 | +0.0390 | +17.65% |
|
Sep 2025 (Q3)
|
$0.23 | $0.16 | +0.0668 | +40.93% |
|
Jun 2025 (Q2)
|
$0.16 | $0.15 | +0.0104 | +6.95% |
Financial Statements
| Revenues | $298.30M |
| Benefits Costs and Expenses | $33.78M |
| Cost Of Revenue | $30.60M |
| Costs And Expenses | $173.81M |
| Gross Profit | $267.70M |
| Operating Expenses | $167.30M |
| Research and Development | $34.23M |
| Other Operating Expenses | $141.64M |
| Operating Income/Loss | $124.49M |
| Income/Loss From Continuing Operations After Tax | $298.21M |
| Income/Loss From Continuing Operations Before Tax | $175.16M |
| Income Tax Expense/Benefit | -$164.48M |
| Income Tax Expense/Benefit, Deferred | -$166.92M |
| Net Income/Loss | $298.21M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $298.21M |
| Net Income/Loss Available To Common Stockholders, Basic | $298.21M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.26 |
| Diluted Earnings Per Share | $2.17 |
| Basic Average Shares | 398,260,000 |
| Diluted Average Shares | 410,914,000 |
| Assets | $724.00M |
| Current Assets | $480.24M |
| Inventory | $46.41M |
| Other Current Assets | $433.83M |
| Noncurrent Assets | $243.75M |
| Fixed Assets | $1.99M |
| Other Non-current Assets | $241.77M |
| Liabilities | $156.37M |
| Current Liabilities | $86.56M |
| Accounts Payable | $2.66M |
| Wages | $8.62M |
| Other Current Liabilities | $75.28M |
| Noncurrent Liabilities | $69.82M |
| Equity | $567.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $567.63M |
| Liabilities And Equity | $724.00M |
| Net Cash Flow From Operating Activities | $166.92M |
| Net Cash Flow From Operating Activities, Continuing | $166.92M |
| Net Cash Flow From Investing Activities | -$81.88M |
| Net Cash Flow From Investing Activities, Continuing | -$81.88M |
| Net Cash Flow From Financing Activities | -$110.46M |
| Net Cash Flow From Financing Activities, Continuing | -$110.46M |
| Net Cash Flow | -$25.42M |
| Net Cash Flow, Continuing | -$25.42M |
| Comprehensive Income/Loss | $297.93M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $298.01M |
| Other Comprehensive Income/Loss | $34.07M |